William Blair Downgrades Ginkgo Bioworks Holdings to Underperform
Portfolio Pulse from Benzinga Newsdesk
William Blair analyst Matt Larew downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Market Perform to Underperform.
May 10, 2024 | 1:49 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ginkgo Bioworks Holdings was downgraded by William Blair from Market Perform to Underperform, indicating a negative outlook on the stock by the analyst.
Analyst ratings can significantly influence investor perception and stock price. A downgrade to Underperform suggests that the analyst believes the stock will not perform as well as the overall market in the near term, potentially leading to a decrease in its stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100